These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12364)

  • 1. The concentration of basic and acidic compounds in guinea-pig lung [proceedings].
    Drew G; Nicholls PJ
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():84P. PubMed ID: 12364
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary absorption of drugs in the neonatal and adult guinea pig.
    Hemberger JA; Schanker LS
    Drug Metab Dispos; 1983; 11(6):615-6. PubMed ID: 6140150
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of ascorbic acid deficiency on extrahepatic microsomal metabolism of drugs and carcinogens in the guinea pig.
    Kuenzig W; Tkaczevski V; Kamm JJ; Conney AH; Burns JJ
    J Pharmacol Exp Ther; 1977 Jun; 201(3):527-33. PubMed ID: 864591
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of in vitro drug metabolism by lung, liver, and kidney of several common laboratory species.
    Litterst CL; Mimnaugh EG; Reagan RL; Gram TE
    Drug Metab Dispos; 1975; 3(4):259-65. PubMed ID: 240655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ion-association on the transcorneal transport of drugs [proceedings].
    Davis SS; Tomlinson E; Wilson CG; Crossland J
    Br J Pharmacol; 1978 Nov; 64(3):444P. PubMed ID: 719290
    [No Abstract]   [Full Text] [Related]  

  • 6. The biological significance of prostaglandin-like substances released from immunologically challenged guinea-pig lungs [proceedings].
    Boot JR; Dawson W; Osborne DJ
    Br J Pharmacol; 1976 Nov; 58(3):471P. PubMed ID: 990646
    [No Abstract]   [Full Text] [Related]  

  • 7. PGI2 release from guinea-pig lungs: detection and bioassay [proceedings].
    Alabaster VA; Hawkeswood E
    Br J Pharmacol; 1978 Mar; 62(3):467P. PubMed ID: 346135
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the beta-adrenoceptors in guinea-pig lung mast cells [proceedings].
    van der Heijden PJ; Zaagsma J
    Br J Pharmacol; 1980 Jan; 68(1):152P. PubMed ID: 6244027
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of large doses of ascorbic acid on the hepatic and extra-hepatic drug-metabolizing enzymes in guinea pig.
    Khanduja KL; Koul A; Koul IB; Gupta MP
    Biochem Int; 1986 Oct; 13(4):659-70. PubMed ID: 3801039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenoceptor binding in guinea-pig lung using [3H]-prazosin [proceedings].
    Barnes PJ; Dollery CT; Hamilton CA; Karliner JS
    Br J Pharmacol; 1980 Jan; 68(1):138P. PubMed ID: 6244025
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of slow-reacting substance from guinea-pig and human lung by calcium ionophore A23187 [proceedings].
    Piper PJ; Seale JP
    Br J Pharmacol; 1978 Jun; 63(2):364P-365P. PubMed ID: 27275
    [No Abstract]   [Full Text] [Related]  

  • 12. Transport of cations by the guinea-pig placenta perfused in situ [proceedings].
    Bradbury MW; France VM; Hedley R; Parry H
    J Physiol; 1977 Oct; 272(1):22P-23P. PubMed ID: 592128
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in arachidonate metabolism between guinea-pig, rat and human isolated lung [proceedings].
    Al-Ubaidi F; Bakhle YS
    J Physiol; 1979 Jun; 291():41P-42P. PubMed ID: 383953
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between parathion and paraoxon toxicokinetics, lung metabolic activity, and cholinesterase inhibition in guinea pig and rabbit lungs.
    Lessire F; Gustin P; Delaunois A; Bloden S; Nemmar A; Vargas M; Ansay M
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):201-10. PubMed ID: 8658521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of arachidonic acid in guinea-pig isolated lungs [proceedings].
    Al-Ubaidi F; Bakhle YS; Jose PJ; Seale JP
    J Physiol; 1978 Aug; 281():2P-3P. PubMed ID: 702371
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between prostaglandin inactivation and release in challenged guinea-pig lungs [proceedings].
    Crutchley DJ; Piper PF; Seale JP
    J Physiol; 1977 Mar; 266(1):52P-53P. PubMed ID: 853416
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of arachidonate lipoxygenase substrates and inhibitors on SRS-A release in the guinea-pig lung [proceedings].
    Morris HR; Piper PJ; Taylor GW; Tippins JR
    Br J Pharmacol; 1979 Jul; 66(3):452P. PubMed ID: 118794
    [No Abstract]   [Full Text] [Related]  

  • 18. The pulmonary uptake, accumulation, and metabolism of xenobiotics.
    Bend JR; Serabjit-Singh CJ; Philpot RM
    Annu Rev Pharmacol Toxicol; 1985; 25():97-125. PubMed ID: 3890717
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of prostaglandins and rabbit aorta contracting substance (RCS) from guinea-pig lung by slow reacting substance of anaphylaxis (SRS-A) [proceedings].
    Engineer DM; Piper PJ; Sirois P
    Br J Pharmacol; 1977 Mar; 59(3):444P. PubMed ID: 843692
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.